Comment: caspofungin acetate for treatment of invasive fungal infections.
Chan
Jeff
J
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000077336:Caspofungin; D004357:Drug Synergism; D054714:Echinocandins; D006168:Guinea Pigs; D006801:Humans; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D000077336:Caspofungin; D065819:Voriconazole